NDAINJECTIONINJECTABLEPriority Review
Approved
Jul 1950
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
LEVOPHED (norepinephrine bitartrate) by Pfizer is (alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action). First approved in 1950.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LEVOPHED (norepinephrine bitartrate) is a catecholamine vasopressor indicated for acute hypotension and cardiogenic shock in critical care settings. It works via dual alpha-adrenergic (vasoconstriction) and beta-adrenergic (inotropic/coronary vasodilation) mechanisms to restore blood pressure and cardiac output in hemodynamically unstable patients.
LOE Approaching
As LOE approaches, expect defensive commercialization strategy focused on brand loyalty, formulary positioning, and managed care contracting rather than growth initiatives.
Mechanism of Action
(alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LEVOPHED offers limited growth opportunity but provides stable, mission-critical exposure to hospital and critical care commercial infrastructure. This role suits professionals seeking deep expertise in managed care negotiations, hospital formulary strategy, and cost-of-goods optimization in a mature, high-volume essential medication.
Brand ManagerAccount Executive (Hospital/IDN)
Worked on LEVOPHED at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.